US intelligence officials told American lawmakers in February that the pharmaceutical firm WuXi AppTec Co. transferred a client’s intellectual property to Chinese authorities without permission, Reuters reported, citing unnamed sources.
The information was provided to about a dozen senators working on a bill that could restrict business with Chinese biotech companies on national security grounds, according to the report. Reuters didn’t disclose the name of WuXi’s client or the specifics of the information that was shared with Beijing.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.